Dongguan HEC TaiGen Biopharmaceuticals

Dongguan HEC TaiGen Biopharmaceuticals Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Financing Rounds
  • 2

Dongguan HEC TaiGen Biopharmaceuticals General Information

Description

Manufacturer of medicines for viral diseases. The company's medicines include protease inhibitor and NS5a inhibitor which are for all-oral treatment of chronic hepatitis C virus (HCV) infection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Dongguang
  • China

Dongguan HEC TaiGen Biopharmaceuticals Timeline

201820192020
Date FoundedFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dongguan HEC TaiGen Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dongguan HEC TaiGen Biopharmaceuticals‘s full profile, request access.

Request a free trial

Dongguan HEC TaiGen Biopharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dongguan HEC TaiGen Biopharmaceuticals‘s full profile, request access.

Request a free trial